Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship | Diabetology & Metabolic Syndrome | Full Text
Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease | NEJM
Development of a plasminogen activator inhibitor (PAI-1) assay and comparison of plasma PAI-1 activity in hyperlipidemic/dyslipidemic dogs with either hyperadrenocorticism or diabetes mellitus, and healthy dogs - ScienceDirect
JDB | Free Full-Text | Inhibition of SERPINE1 Function Attenuates Wound Closure in Response to Tissue Injury: A Role for PAI-1 in Re-Epithelialization and Granulation Tissue Formation
Schematic representation of PAI-1 action. PAI-1 not only inhibits local... | Download Scientific Diagram
PAI-1: An Integrator of Cell Signaling and Migration
Plasminogen activator inhibitor-1 and the kidney | American Journal of Physiology-Renal Physiology
Journal of Cellular Biochemistry | Wiley Online Library
Frontiers | Premature delivery impacts the concentration of plasminogen activators and a plasminogen activator inhibitor and the plasmin activity in human milk
Plasminogen Activator Inhibitor-1 (PAI-1): Regulator of clotting
IJMS | Free Full-Text | PAI-1, the Plasminogen System, and Skeletal Muscle
PAI-1とは | ナノピア®PAI-1 | 積水メディカル株式会社
PDF] Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis. | Semantic Scholar
Plasminogen Activator Inhibitor Type 1 Deficiency
PAI-1 protein is a key molecular effector in the transition from normal to PTSD-like fear memory | Molecular Psychiatry
Plasminogen Activator Inhibitor (PAI) - YouTube
British Journal of Haematology | Wiley Online Library